TABLE 4.

Temporal onset of GM antigenemia in patients with proven and probable IA

Time pointaNo. of evaluable patientsNo (%) of patients with GM antigenDays between GM antigen detection and time point median (range)
First day of fever71 (14.3)4 (4)
First day of clinical signsb73 (42.8)9 (4-15)
Pulmonary HRCT scan76 (85.7)7.2 (1-15)
Initation of antifungal therapy74 (57.1)12.5 (1-23)
  • a At or before time point.

  • b Cough and/or dyspnea and/or hemoptysis and/or thoracic pain.